Key facts
- This page summarizes Marlan D. Walker's Form 4 filing for TherapeuticsMD, Inc. (TXMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Apr 2025, 07:59.
Marlan D. Walker - 14 Apr 2025 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- TXMD
- Reported as of
- 14 Apr 2025
- Net transaction value
- +$489
- SEC form
- 4
- Accepted by SEC
- 15 Apr 2025, 07:59:22 UTC
- Prior SEC filing
- 10 Apr 2025
- Next SEC filing
- 05 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marlan D. Walker
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Marlan D. Walker filed Form 4 for TherapeuticsMD, Inc. (TXMD) on 15 Apr 2025.
Change
- Previous filing in this sequence was filed on 10 Apr 2025.
- Current net transaction value: +$489.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TXMD
transaction
Common Stock
Purchase
- Transaction value
- $489
- Shares
- +490
- Change %
- +0.67%
- Price
- $0.9985
- Shares after
- 73,639
- Date
- 14 Apr 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.